Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1609054/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849691811631595520 |
|---|---|
| author | Regina Berkovich Jonathan Calkwood Heidi Crayton April Erwin Simon Faissner Ralf Gold Joshua Katz Mark Leekoff |
| author_facet | Regina Berkovich Jonathan Calkwood Heidi Crayton April Erwin Simon Faissner Ralf Gold Joshua Katz Mark Leekoff |
| author_sort | Regina Berkovich |
| collection | DOAJ |
| format | Article |
| id | doaj-art-83c5cb15ba0844d4988fe9b5823895ae |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-83c5cb15ba0844d4988fe9b5823895ae2025-08-20T03:20:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-06-011610.3389/fimmu.2025.16090541609054Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report seriesRegina Berkovich0Jonathan Calkwood1Heidi Crayton2April Erwin3Simon Faissner4Ralf Gold5Joshua Katz6Mark Leekoff7Regina Berkovich MD, PhD Inc (MS Center and Research Institute), West Hollywood, CA, United StatesDepartment of Neurology, Minnesota Center for Multiple Sclerosis, Plymouth, MN, United StatesDepartment of Neurology, MS Center of Greater Washington, Vienna, VA, United StatesDepartment of Neurology, Rocky Mountain MS Clinic, Salt Lake City, UT, United StatesDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, GermanyDepartment of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Bochum, GermanyDepartment of Neurology, The Elliot Lewis Center, Wellesley, MA, United StatesAtlantic Medical Group Multiple Sclerosis Comprehensive Care Center, Bridgewater, NJ, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1609054/fullanti-CD20B-cell depletiondisabilitymagnetic resonance imagingmultiple sclerosisocrelizumab |
| spellingShingle | Regina Berkovich Jonathan Calkwood Heidi Crayton April Erwin Simon Faissner Ralf Gold Joshua Katz Mark Leekoff Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series Frontiers in Immunology anti-CD20 B-cell depletion disability magnetic resonance imaging multiple sclerosis ocrelizumab |
| title | Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series |
| title_full | Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series |
| title_fullStr | Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series |
| title_full_unstemmed | Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series |
| title_short | Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series |
| title_sort | corrigendum switching to ublituximab from prior anti cd20 monoclonal antibody therapy a case report series |
| topic | anti-CD20 B-cell depletion disability magnetic resonance imaging multiple sclerosis ocrelizumab |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1609054/full |
| work_keys_str_mv | AT reginaberkovich corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT jonathancalkwood corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT heidicrayton corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT aprilerwin corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT simonfaissner corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT ralfgold corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT joshuakatz corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries AT markleekoff corrigendumswitchingtoublituximabfromprioranticd20monoclonalantibodytherapyacasereportseries |